11th Annual Winship Cancer Institute Gastrointestinal Cancer Symposium



This hybrid (in-person or virtual https://cmetracker.net/EMORY/Publisher?page=pubOpen#/EventID/15214) symposium will present expert review of the latest procedures, technology and medical treatments for GI cancer patients. National guidelines will be reviewed. Emphasis will be on multidisciplinary care, novel new drugs that have been recently FDA approved, and upcoming clinical trials.

On the agenda:

  • Borderline Resectable Pancreatic Cancer after Induction Chemotherapy: Consolidation Chemo-Radiotherapy or Alternative Chemotherapy Regimens?
  • Emerging Treatment Options in Advanced Pancreatic Cancer
  • Expanding Treatment Options in Biliary Tract Cancers
  • Navigating the Comprehensive Genomic Profiling (CGP) Report
  • Updates on Systemic Therapies in HCC Management
  • Advances in Immuno-Oncology Agents in the Management of Esophagogastric Cancers
  • Sequencing of Systemic Therapy and PRRT in Neuroendocrine Tumors
  • Updates in the Management of Gastrointestinal Stromal Tumors (GIST); Role of Locoregional and Systemic Therapies
  • Controversies in Adjuvant Colorectal Cancer Therapy
  • Radiation as a Locoregional Treatment Option for Colorectal Liver Metastases
Format: Lectures, Case presentations with Q&A, debates (High Tumor Mutational Burder(TMB) Alone Is Not Sufficient for Immunotherapy; First-Line Treatment in Left-Sided, RAS/BRAF Wild-Type Metastatic Colorectal Cancer: Wait for Molecular Results to Start EGFR Inhibitors vs Proceed with VEGF Inhibitors?) 5 AMA PRA Category 1 Credits™ - maximum

5 ABIM MOC points

5 CNE contact hours

Venue: JW Marriott Atlanta Buckhead


October 8, 2022


Atlanta, Georgia 30326, United States